This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Perlen Packaging and Etimex Primary Packaging are working together to further establish the polypropylene (PP) monoblister in the pharmaceutical industry. Their objective is to jointly market and distribute Etimex’s PP monoblister product. Both companies are well known in the market for their individual and specialized blister solutions and play a pioneering role with regard to environmental protection, sustainability, the responsible use of resources, and CO2 emissions reduction.
Sustainability aspects also constitute an increasingly important competitive factor in the pharmaceutical industry. Sustainable packaging is, therefore, a logical step toward future viability for customers in the pharmaceutical industry.
Recyclable packaging solutions in the food and pharmaceutical industries are a “must” for Etimex. The company views the cooperation with a specialist in the pharmaceutical industry such as Perlen Packaging as a great opportunity to establish polypropylene blister packaging as a viable alternative for companies in the market.
Martin Rank, head of sales & marketing at Etimex Primary Packaging, says, “Our sustainable PP mono blister Purelay Pharm is a perfect complement to Perlen Packaging’s range of packaging solutions. We are now pleased to make our long-standing expertise in recyclable polypropylene packaging available to new customers and markets. We are committed to working together with Perlen Packaging to achieve this.”
“We are responding to our customers’ requests and expanding our existing PVC/PVdC product range,” adds Lars Kirchhoff, chief sales officer of Perlen Packaging. “The cooperation with Etimex enables us to offer a tried and tested, fully recyclable solution based on polypropylene from a single source.”